MASS
908 Devices Inc.
NASDAQ · Healthcare · Medical - Devices · US
$10.53
−4.10%Year over year
Reported trailing growth
- Revenue
- +4.6%
- EBITDA
- -4.9%
- EBIT
- +60.5%
- EPS
- -69.1%
- Free cash flow
- +101.7%
- Operating cash flow
- +104.8%
Forward estimates
Based on analyst estimates
- Revenue
- +24.5%
- EBITDA
- +45.0%
- EPS
- +39.0%
Three-year CAGR
- Revenue
- +6.2%
- EBITDA
- +34.2%
- EBIT
- +68.5%
- Net income
- +49.3%
- EPS
- +52.4%
- Free cash flow
- +20.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026